RESEARCH PAPER
Effect of polyamines on the nicotinic ACh receptor
 
More details
Hide details
1
Laboratory of Physiology and Pathophysiology, Centre for Preclinical Research and Technology (CePT), Medical University of Warsaw, Poland
2
Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Rimini, Italy
3
Department of Biophysics, Warsaw University of Life Sciences SGGW, Warsaw, Poland
 
J Pre Clin Clin Res. 2018;12(3):73–76
KEYWORDS:
TOPICS:
ABSTRACT:
Introduction:
In recent years, interactions of various polyamines with a number of ionotropic receptors have been reported. Such interactions can be either negative (inhibition) or positive (potentiation). It is proposed that hydrophilic polyamines act as open-channel blockers and bind sites deeply in the ion channel pore. Hydrophobic polyamines are believed to act in the shallower part of the pore. There has been cause to think that polyamines with two aromatic moieties block the nicotinic acetylcholine (nACh) receptor by adopting a U-shaped conformation, that is, a conformation in which the long positively charged polyamine chain enters the ion channel while aromatic moieties interact with extracellular parts of α-subunits.

Objective:
Our goal was to determine whether and how changes in the structure of methoctramine (a polyamine with two aromatic moieties) affect the way in which the nACh receptor is blocked. We synthesized derivatives of methoctramine which have a less flexible structure than methoctramine itself and may be less capable of adopting a U-shaped conformation within the ion channel.

Material and methods:
.Whole-cell ACh-induced currents were recorded from mouse i28 satellite cells expanded in culture. Recordings were performed both in the presence and in the absence of polyamines.

Results:
All tested polyamines applied at a concentration of 5 mM blocked ACh-induced currents. Depending on the number of protonated nitrogen atoms, polyamines decreased the current amplitude and/or increased the decay rate of the current.

Conclusions:
We propose two possible mechanisms to explain the action of polyamines: desensitization, and displacement of agonist molecules from their binding sites. The impact of the number of protonated nitrogen atoms is discussed.

CORRESPONDING AUTHOR:
Ewa Nurowska   
Laboratory of Physiology and Pathophysiology, Centre for Preclinical Research and Technology (CePT), Medical University of Warsaw, 02-097 Warsaw, Poland, Banacha 1b, 02-097 Warsaw, Poland
 
REFERENCES (17):
1. Kachel HS, Patel RN, Franzyk H, Mellor IR. Block of nicotinic acetylcholine receptors by philanthotoxins is strongly dependent on their subunit composition. Scientific Reports. 2016; 6: 38116.
2. Perrais D, Veran J, Mulle C. Gating and permeation of kainate receptors: differences unveiled. Trends Pharmacol Sci. 2010; 31(11): 516–22.
3. Strømgaard K, Mellor I. AMPA receptor ligands: synthetic and pharmacological studies of polyamines and polyamine toxins. Med Res Rev. 2004; 24(5): 589–620.
4. Chatzidaki A, Millar NS. Allosteric modulation of nicotinic acetylcholine receptors. Biochem Pharmacol. 2015; 97(4): 408–417.
5. Usherwood PNR. Natural and synthetic polyamines: modulators of signalling proteins. Farmaco. 2000; 55(3): 202–205.
6. Shao Z, Mellor IR, Brierley MJ, Harris J, Usherwood PNR. Potentiation and inhibition of nACh receptors by spermine in the TE671 human muscle cell line. J Pharmacol Exp Ther. 1998; 286(3): 1269–1276.
7. Brier TJ, Mellor IR, Tikhonov DB, Neagoe I, Shao Z, Brierley MJ, Strømgaard K, Jaroszewski JW, Krogsgaard-Larsen P, Usherwood PN. Contrasting actions of Philantotoxin-343 and Philantotoxin-(12) on human muscle nACh receptors. Mol Pharmacol. 2003; 64: 994–964.
8. Nurowska E, Tumiatti V, Minarini A, Ruzzier F. Methoctramine effects on nicotinic acetylcholine receptor kinetics. Acta Physiologica. 2006; 188, Suppl 652: 37–38.
9. Bixel MG, Krauss M, Liu Y, Bolognesi ML, Rosini M, Mellor IS, Usherwood PN, Melchiorre C, Nakanishi K, Hucho F. Structure-activity relationship and site of binding of polyamine derivatives at the nicotinic acetylcholine receptor. Eur J Biochem. 2000; 267:110–120.
10. Rosini M, Budriesi R, Bixel MG, Bolognesi ML, Chiarini A, Hucho F, Krogsgaard-Larsen P, Mellor IR, Minarini A, Tumiatti V, Usherwood PN, Melchiorre C.Design, synthesis, and biological evaluation of symmetrically and unsymmetrically substituted methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. J Med Chem. 1999; 42: 5212–5223.
11. Jakubík J, Zimčík P, Randáková A, Fuksová K, El-Fakahany EE, Doležal V. Molecular mechanisms of methoctramine binding and selectivity at muscarinic acetylcholine receptors. Mol Pharmacol. 2014; 86(2): 180–192.
12. Tumiatti V, Minarini A, Milelli A, Rosini M, Buccioni M, Marucci G, Ghelardini C, Bellucci C, Melchiorre C. Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moieties. Bioorg Med Chem. 2007; 15(6): 2312–2321.
13. Marty A, Neher E. Tight-Seal Whole-Cell Recording. In: Sakmann B, Neher E, editors. Single-Channel Recording. Ed.2. New York and London. 1995. p. 31–51.
14. Lorenzon P, Bernareggi A, Degasperi V, Nurowska E, Wernig A, Ruzzier F. Properties of primary mouse myoblasts expanded in culture. Exp Cell Res. 2002; 278: 84–91.
15. Song XZ, Pedersen SE. Electrostatic interactions regulate desensitization of the nicotinic acetylcholine receptor. Biophys J. 2000; 78: 1324–1334.
16. Colquhoun D, Hawkes AG, The principles of the stochastic interpretation of ion-channel mechanism, in: Sakmann B, Neher E (Eds.), Single- Channel Recordings, Plenum, New York, 1995, pp. 397–482.
17. Dworakowska B, Nurowska E, Dołowy K. Hydrocortisone inhibition of wild-type and αd200Q nicotinic acetylcholine receptors. Chem Biol Drug Des. 2018; 92(3): 1610–1617.
eISSN:1898-7516
ISSN:1898-2395